Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

2.90USD
6 Dec 2016
Change (% chg)

-- (+0.00%)
Prev Close
$2.90
Open
$2.85
Day's High
$3.00
Day's Low
$2.75
Volume
271,016
Avg. Vol
300,082
52-wk High
$5.01
52-wk Low
$2.40

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.24 December 6 Dec 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.17 2.17 2.17 2.17

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 6 3.71 6.50 2.00 1.49
Quarter Ending Mar-17 5 1.75 3.40 0.10 --
Year Ending Dec-16 6 13.85 15.50 12.80 6.42
Year Ending Dec-17 6 7.63 15.00 0.60 11.90
Earnings (per share)
Quarter Ending Dec-16 6 -0.24 -0.12 -0.30 -0.17
Quarter Ending Mar-17 5 -0.27 -0.20 -0.32 --
Year Ending Dec-16 6 -0.98 -0.86 -1.04 -0.82
Year Ending Dec-17 6 -1.10 -0.82 -1.34 -0.73

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 2.89 3.37 0.48 16.60
Quarter Ending Jun-16 2.17 4.53 2.36 108.47
Quarter Ending Mar-16 1.62 3.03 1.41 86.73
Quarter Ending Dec-15 4.97 1.73 3.24 65.17
Quarter Ending Sep-15 1.75 15.43 13.68 781.60
Earnings (per share)
Quarter Ending Sep-16 -0.23 -0.25 0.02 -7.16
Quarter Ending Jun-16 -0.22 -0.24 0.02 -9.09
Quarter Ending Mar-16 -0.20 -0.25 0.05 -22.55
Quarter Ending Dec-15 -0.10 -0.24 0.14 -140.00
Quarter Ending Sep-15 -0.23 0.12 0.35 -152.56

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-16 3.71 3.71 3.51 3.51 1.49
Quarter Ending Mar-17 1.75 1.75 0.79 0.79 --
Year Ending Dec-16 13.85 13.85 13.45 13.45 6.42
Year Ending Dec-17 7.63 7.63 7.41 7.41 11.90
Earnings (per share)
Quarter Ending Dec-16 -0.24 -0.24 -0.24 -0.24 -0.17
Quarter Ending Mar-17 -0.27 -0.27 -0.25 -0.22 --
Year Ending Dec-16 -0.98 -0.98 -0.93 -0.91 -0.82
Year Ending Dec-17 -1.10 -1.10 -1.08 -1.08 -0.73

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-16 0 0 4 2
Quarter Ending Mar-17 0 0 2 0
Year Ending Dec-16 0 0 2 3
Year Ending Dec-17 0 0 3 2
Earnings
Quarter Ending Dec-16 0 0 2 4
Quarter Ending Mar-17 0 0 0 3
Year Ending Dec-16 0 0 1 5
Year Ending Dec-17 0 0 3 3